Learn More
Abnova™ Human ABL1 (NM_005157.3, 118 a.a. - 535 a.a.) Q252H mutant Partial Recombinant Protein expressed in Sf9 cells
Shop All Abnova Corporation ProductsDescription
The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq]
Specifications
Specifications
| Accession Number | NM_005157.3 |
| Concentration | 0.242 ug/uL |
| For Use With (Application) | Functional Study, SDS-PAGE |
| Formulation | Liquid |
| Gene ID (Entrez) | 25 |
| Molecular Weight (g/mol) | 76.176kDa |
| Name | ABL1 (Q252H) (Human) Recombinant Protein |
| Preparation Method | Insect cell (Sf9) expression system |
| Purification Method | GST affinity chromatography |
| Quality Control Testing | 2 ug/lane SDS-PAGE Stained with Coomassie Blue |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.